NUFORMIX TECHNOLOGIES LIMITED
Company number 06407331 · Monitor this company
Executive summary
NUFORMIX TECHNOLOGIES LIMITED displayed severe financial distress as of July 2015, with technical insolvency (net liabilities of £95,903), a critical working capital deficit of £211,516, and accumulated losses exceeding £600,000. However, the company's continued existence and recent filing activity strongly suggest the post year-end licensing agreement and parent company support have provided the necessary "life support" for recovery. The company's patent portfolio represents its primary value driver, and successful monetisation through licensing will be essential to transforming from a chronic cash-burn patient into a financially healthy business.
Shareholders' funds
-£95,903
Balance sheet as at 2015-07-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2007-10-23
- Registered office
- C/O Arch Law Limited Huckletree Bishopsgate, 8 Bishopsgate, London, United Kingdom, EC2N 4BQ
- Postcode
- EC2N 4BQ
- Capital
- 0 GBP
- Accounts category
- Full
Accounts
- Last made up to
- 2025-09-30
- Next due by
- 2027-06-30
- Financial year end
- 30 September
Confirmation statement
- Last statement dated
- 2025-10-23
- Next due by
- 2026-11-06
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 7 current · 11 resigned
Group structure
Controlled by NUFORMIX PLC — since 2017-10-13
From persons-with-significant-control filings on the public register.
Contact details
- Website
- nuformix.com
Nuformix is a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing
Previous company names
| Name | Date changed |
|---|---|
| NUFORMIX LIMITED | 2017-10-13 |
| SANDCO 1049 LIMITED | 2007-12-10 |
Previous registered addresses 3
| Address | Changed on |
|---|---|
| SANDGATE HOUSE, 102 QUAYSIDE, NEWCASTLE UPON TYNE, TYNE & WEAR, NE1 3DX | 2020-08-06 |
| THE WILTON CENTRE WILTON, REDCAR, TEESSIDE, TS10 4RF | 2018-05-16 |
| SANDGATE HOUSE, 102 QUAYSIDE, NEWCASTLE UPON TYNE, TYNE & WEAR, NE1 3DX | 2008-08-06 |
Among its peers
Among the oldest 25%
of 245 similar companies in EC, trading since 2007
Competitors London
This company ranks 112 among research and experimental development on biotechnology in London.
The class of 2007
28%
of the 228,174 companies incorporated in 2007 are still active today; 69% have since been dissolved.
A fact about the year, not a forecast for this company.